P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.

• Aniket Bhide,
• Gaurav Chatterjee,
• Sweta Rajpal,
• Swapnali Joshi,
• Vishram Terse,
• Dhanlaxmi Shetty,
• Anant Gokarn,
• Sachin Punatar,
• Nishant Jindal,
• Bhausaheb Bagal,
• Lingaraj Nayak,
• Hasmukh Jain,
• Navin Khattry,
• Manju Sengar,
• Prashant Tembhare,
• Sumeet Gujral,
• Papagudi Subramanian,
• Nikhil Patkar

Affiliations

Aniket Bhide

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Gaurav Chatterjee

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Sweta Rajpal

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Swapnali Joshi

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Vishram Terse

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Dhanlaxmi Shetty

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Anant Gokarn

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Sachin Punatar

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Nishant Jindal

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Bhausaheb Bagal

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Lingaraj Nayak

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Hasmukh Jain

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Navin Khattry

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Manju Sengar

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Prashant Tembhare

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Sumeet Gujral

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Papagudi Subramanian

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India

Nikhil Patkar

1 Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Hematopathology, Navi Mumbai, India